Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO – Get Free Report) traded down 3.9% during mid-day trading on Wednesday . The company traded as low as $0.47 and last traded at $0.48. 128,888 shares traded hands during trading, a decline of 83% from the average session volume of 739,872 shares. The stock had previously closed at $0.50.
Wall Street Analysts Forecast Growth
Separately, Benchmark upped their target price on shares of Cardio Diagnostics from $1.35 to $2.00 and gave the stock a “speculative buy” rating in a report on Thursday, June 6th.
Read Our Latest Report on CDIO
Cardio Diagnostics Price Performance
Hedge Funds Weigh In On Cardio Diagnostics
An institutional investor recently bought a new position in Cardio Diagnostics stock. Vontobel Holding Ltd. bought a new stake in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,000 shares of the company’s stock, valued at approximately $30,000. Vontobel Holding Ltd. owned about 0.06% of Cardio Diagnostics at the end of the most recent reporting period. Institutional investors own 8.06% of the company’s stock.
Cardio Diagnostics Company Profile
Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Featured Articles
- Five stocks we like better than Cardio Diagnostics
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- How to invest in marijuana stocks in 7 steps
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.